Home/Filings/4/0000874015-25-000136
4//SEC Filing

BERTHELSEN SPENCER R 4

Accession 0000874015-25-000136

CIK 0000874015other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:52 PM ET

Size

8.9 KB

Accession

0000874015-25-000136

Insider Transaction Report

Form 4
Period: 2025-07-01
Transactions
  • Award

    Restricted Stock Unit

    2025-07-01+5,2209,299 total
    Exercise: $0.00Common Stock (5,220 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2025-07-01+11,51811,518 total
    Exercise: $39.94From: 2026-07-01Exp: 2035-06-30Common Stock (11,518 underlying)
Footnotes (4)
  • [F1]Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2025 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718.
  • [F2]Grant on July 1, 2025 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2025.
  • [F3]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
  • [F4]Grant on July 1, 2025 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2025.

Issuer

IONIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001181548

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:52 PM ET
Size
8.9 KB